Agenus - mark

At Agenus, we believe the best path for treating disease is through activating our own body’s natural mechanisms.

That’s why for 20 years, we’ve focused on building technologies and a product pipeline aimed at treating cancer and infectious disease by helping the body’s immune system target diseased cells with precision.

  • February 26, 2015

    Agenus Reports Fourth Quarter and Full Year 2014 Financial Results
    Read More


  • February 25, 2015

    Agenus to Present at the Cowen and Company 35th Annual Health Care Conference
    Read More


  • February 20, 2015

    Agenus to Report Fourth Quarter and Year End 2014 Financial Results on February 26, 2015; Conference Call to Follow
    Read More


  • February 3, 2015

    Agenus to Present at the 17th Annual BIO CEO & Investor Conference
    Read More


  • January 9, 2015

    Incyte and Agenus Announce Global Alliance to Develop Novel Immuno-Oncology Antibodies
    Read More


  • December 18, 2014

    Positive Outcome of Phase 3 Study of GSK Shingles Vaccine Containing Agenus Adjuvant
    Read More